Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel application of mir-3620

A mir-3620, mature technology, applied in the new application field of mir-3620 and its mature miRNA in the diagnosis and treatment of colon adenocarcinoma, which can solve problems such as affecting the normal physiological function of cells and diseases

Active Publication Date: 2016-12-21
QINGDAO MEDINTELL BIOMEDICAL CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The abnormality of miRNA expression and activity is very likely to affect the normal physiological function of cells and lead to the occurrence of diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel application of mir-3620
  • Novel application of mir-3620
  • Novel application of mir-3620

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] The collection of embodiment 1 sample and total RNA extraction

[0053] From January 2014 to August 2015, 6 cases of cancer tissues and corresponding paracancerous tissues were collected from patients with colon adenocarcinoma. The patients did not receive radiotherapy and chemotherapy before the operation, and the materials were collected during the operation, stored in liquid nitrogen immediately, and then transferred to -80°C for long-term storage for RNA extraction. The specimen was diagnosed as colon cancer by pathological diagnosis.

[0054] RNA extraction standards: RNA purity: OD260 / 280≧1.8, 28S / 18S≧1; RNA integrity: RIN value≧7.0. RNA integrity detection method: Agilent 2100 (RNA 6000Nano kit), agarose gel electrophoresis (agarose gel concentration: 1% agarose gel; voltage: 5V / cm; time: 20min).

Embodiment 2

[0055] Example 2 Sequencing and Data Integration Analysis

[0056] Sequencing: The miRNA was sequenced using llumina Hiseq2500 / Miseq second-generation high-throughput sequencing technology, and the data processing was completed through the processes of removing adapters, removing low-quality, and decontaminating to obtain the final data.

[0057] Meta-analysis: The nationalwidechildrens.org_clinical_patient_coad file of the TCGA database recorded the clinical information of 459 patients with colon adenocarcinoma. This project excludes 62 patients whose history_other_malignancy or history_neoadjuvant_treatment is Yes, and 337 patients whose histologic_diagnosis is ColonAdenocarcinoma are included in the study (60 patients whose histologic_diagnosis is Colon MucinousAdenocarcinoma, [Not Available], [Discrepancy] are not included in the study). The miRNA data in the TCGA database of 337 patients with colon adenocarcinoma (COAD) were used for analysis. These data are from the Pri...

Embodiment 3

[0059] Example 3 Detection of miR-3620-3p expression in colon adenocarcinoma tissue by Real-time PCR

[0060] 1 sample collection:

[0061] Cancer tissues and paracancerous tissues of 36 patients with colon adenocarcinoma (collection time from January 2014 to August 2015).

[0062] 2 total RNA extraction:

[0063] Removal of RNase for related experimental items:

[0064] ① Rinse and soak all glassware with DEPC before use, 120°C for 20 minutes under high pressure, and 180°C for more than 2 hours.

[0065] ②Plastic utensils (such as: EP tubes / tips) need to be soaked in 0.1% DEPC water overnight before use, and then the liquid is controlled to dry, 120°C and high pressure for 20 minutes, and dried in an oven for later use.

[0066] leukapheresis

[0067] (1) Take 2m1 anticoagulated peripheral blood (blood collection time does not exceed 3h);

[0068] (2) Add an equal volume of sterile PBS to the peripheral blood and mix thoroughly to form a cell suspension;

[0069] (3) Add ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a novel application of mir-3620, in particular to novel applications of the mir-3620 and mature miRNA thereof in diagnosing and treating colon adenocarcinoma. According to the novel application of the mir-3620, next generation sequencing is conducted on colon adenocarcinoma tissues and para-carcinoma tissues, so that data is obtained, and meanwhile, the obtained data is integrated and analyze in combination with existing data of a database, so that miRNA expression data is obtained and candidate mir-3620 is screened out. Further clinical verification and cell experiment results indicate that miR-3620-3p achieves low expression in the cancer tissues, and the over-expression of the miR-3620-3p can inhibit in vitro proliferation capacity of the colon adenocarcinoma cells. The invention provides a novel colon adenocarcinoma diagnosis and treatment gene for clinical application and lays a foundation for further research and development of related reagents.

Description

technical field [0001] The present invention relates to the field of tumor molecular diagnosis, in particular to the new application of mir-3620 and its mature miRNA, and more specifically to the new application of mir-3620 and its mature miRNA in the diagnosis and treatment of colon adenocarcinoma. Background technique [0002] miRNA is an endogenous non-coding small molecule that regulates gene expression by specifically binding to target genes. A single miRNA can target hundreds of target genes, and the interaction between a large number of miRNAs and target genes plays a crucial role in the regulation of cancer-related signaling pathways. miRNAs function as regulatory feedback and buffers in normal cell physiology, serving as key factors for fine-tuning target gene protein levels and preventing them from exceeding the normal physiological range. In addition, miRNA is also a switch between different molecular signaling pathways. The abnormality of miRNA expression and a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/68C12N15/113A61K45/00A61K31/713A61P35/00
CPCA61K31/713A61K45/00C12Q1/6886C12Q2600/178
Inventor 杨承刚董东杜海威
Owner QINGDAO MEDINTELL BIOMEDICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com